Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium

Toxicology in Vitro

Volumn 30, Issue 1, 2015, Pages 288-299

  Starokozhko, Viktoriia ^a   Abza, Getahun B ^a   Maessen, Hedy C ^a   Merema, Marjolijn T ^a   Kuper, Frieke ^b   Groothuis, Geny M M ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b TNO   (Netherlands)

Author keywords

Precision cut liver slices; Prolonged incubation

Indexed keywords

ALBUMIN; CYTOCHROME P450 3A1; GLYCOGEN; ADENOSINE TRIPHOSPHATE; CULTURE MEDIUM; LACTATE DEHYDROGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BILE DUCT; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; EX VIVO STUDY; FIBROSIS; INCUBATION TIME; LIPID STORAGE; LIVER CELL; LIVER SLICE; MALE; METABOLISM; NONHUMAN; PRECISION CUT LIVER SLICE; RAT; THICKNESS; TOXICITY; ANIMAL; HOMEOSTASIS; IN VITRO STUDY; LIPID METABOLISM; LIVER; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS); WISTAR RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL PROLIFERATION; CULTURE MEDIA; HOMEOSTASIS; IN VITRO TECHNIQUES; L-LACTATE DEHYDROGENASE; LIPID METABOLISM; LIVER; MALE; RATS; RATS, WISTAR;

EID: 84958523702     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.10.008     Document Type: Article

References (77)

1. Acton A.Q. Heart Failure: New Insights for the Healthcare Professional 2013, (Atlanta, Georgia, USA). 2013th ed.
2. Bade E.G., Feindler S. Liver epithelial cell migration induced by epidermal growth factor or transforming growth factor alpha is associated with changes in the gene expression of secreted proteins. In vitro cell. Dev. Biol. 1988, 24(2):149-154.
3. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Invest. 2005, 115(2):209-218.
4. Bhogal R.H., Afford S.C. Autophagy and the liver. Autophagy-A Double-Edged Sword-Cell Survival or Death? 2013, InTech, Croatia. Y. Bailly (Ed.).
5. Boots A.M. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology 1994, 82(2):268-274.
6. Burt A.D. Bile duct proliferation-its true significance?. Histopathology 1993, 23(6):599-602.
7. Cassiman D. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J. Hepatol. 2002, 36(2):200-209.
8. Catania J.R. Induction of CYP2B and CYP2E1 in precision-cut rat liver slices cultured in defined medium. Toxicol. in Vitro 2007, 21(1):109-115.
9. Catania J.M., Parrish A.R., Kirkpatrick D.S., Chitkara M., Bowden G.T., Henderson C.J., et al. Precision-cut tissue slices from transgenic mice as an in vitro toxicology system. Toxicol. in Vitro 2003, 17(2):201-205.
10. Chan C. Metabolic pre-conditioning of cultured cells in physiological levels of insulin: generating resistance to the lipid-accumulating effects of plasma in hepatocytes. Biotechnol. Bioeng. 2002, 78(7):753-760.
11. Chan C., Berthiaume F., Lee K., Yarmush M.L. Metabolic flux analysis of hepatocyte function in hormone- and amino acid-supplemented plasma. Metab. Eng. 2003, 5(1):1-15.
12. Chau Y.Y. The role of Wt1 in regulating mesenchyme in cancer, development, and tissue homeostasis. Trends Genet. 2012, 28(10):515-524.
13. Chen W., Rock J.B., Yearsley M.M., Ferrell L.D., Frankel W.L. Different collagen types show distinct rates of increase from early to late stages of hepatitis C-related liver fibrosis. Hum. Pathol. 2014, 45(1):160-165.
14. Clouzeau-Girard H. Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab. Investig. 2006, 86(3):275-285.
15. Cursio R. The role of autophagy in liver diseases: mechanisms and potential therapeutic targets. Biomed. Res. Int. 2015, 2015.
16. de Graaf I.A.M., van der Voort D., Brits J.H.F.G., Koster H.J. Increased post-thaw viability and phase I and II biotransformation activity in cryopreserved rat liver slices after improvement of a fast-freezing method. Drug Metab. Dispos. 2000, 28(9):1100-1106.
17. de Graaf I.A.M., Groothuis G.M.M., Olinga P. Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opin. Drug Metab. Toxicol. 2007, 3(6):879-898.
18. de Graaf I., Olinga A.M., de Jager P., Merema M.H., de Kanter M.T., R.van de Kerkhof E.G., et al. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat. Protoc. 2010, 5(9):1540-1551.
19. DiZerega G.S., DeCherney A.H., Diamond M.P., Dunn R.C., Goldberg E.P., Haney A.F., et al. Pelvic Surgery: Adhesion Formation and Prevention 1997, Springer.
20. Doostdar H., Duthie S.J., Burke M.D., Melvin W.T., Grant M.H. The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived hep G2 cell line. FEBS Lett. 1988, 241(1-2):15-18.
21. Duryee M.J., Willis M.S., Schaffert C.S., Reidelberger R.D., Dusad A.A., Klassen D.R., et al. Precision-cut liver slices from diet-induced obese rats exposed to ethanol are susceptible to oxidative stress and increased fatty acid synthesis. Am. J. Physiol. Gastrointest. Liver Physiol. 2014, 306(3):G208-G217.
22. Elaut G., Vanhaecke T., Heyden Y.V., Rogiers V. Spontaneous apoptosis, necrosis, energy status, glutathione levels and biotransformation capacities of isolated rat hepatocytes in suspension: effect of the incubation medium. Biochem. Pharmacol. 2005, 69(12):1829-1838.
23. Elferink M.G.L., Olinga P., Draaisma A.L., Merema M.T., Bauerschmidt S., Polman J., et al. Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity. Toxicol. Appl. Pharmacol. 2008, 229(3):300-309.
24. Friedl P. Collective cell migration in morphogenesis, regeneration and cancer. Nat. Rev. Mol. Cell Biol. 2009, 10(7):445-457.
25. Geimer P. The epidermal growth factor-induced migration of rat liver epithelial cells is associated with a transient inhibition of DNA synthesis. J. Cell Sci. 1991, 100:349-355.
26. Goethals F., Deboyser D., Lefebvre V., De Coster I., Roberfroid M. Adult rat liver slices as a model for studying the hepatotoxicity of vincaalkaloids. Toxicol. in Vitro 1990, 4(4-5):435-438.
27. Groothuis G.M.M., Casini A., Meurs H., Olinga P. Translational research in pharmacology and toxicology using precision-cut tissue slices. Royal Society of Chemistry. 2014, 27-38. 1st ed. R. Coleman (Ed.).
28. Guyot C. Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices. J. Hepatol. 2007, 46(1):142-150.
29. Guyot C. Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations. Virchows Arch. 2007, 450(5):503-512.
30. Hadi M., Chen Y., Starokozhko V., Merema M.T., Groothuis G.M.M. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem. Res. Toxicol. 2012, 25(9):1938-1947.
31. Halliwell B. Cell culture, oxidative stress, and antioxidants: avoiding pitfalls. Biomed. J. 2014, 37(3):99-105.
32. Hashemi E., Till C., Ioannides C. Stability of phase II conjugation systems in cultured precision-cut rat hepatic slices. Toxicol. in Vitro 1999, 13(3):459-466.
33. Ijzer J. Morphological characterisation of portal myofibroblasts and hepatic stellate cells in the normal dog liver. Comp. Hepatol. 2006, 5.
34. Ilina O. Mechanisms of collective cell migration at a glance. J. Cell Sci. 2009, 122(Pt):3203-3208.
35. Iyer V.V., Yang H., Ierapetritou M.G., Roth C.M. Effects of glucose and insulin on HepG2-C3A cell metabolism. Biotechnol. Bioeng. 2010, 107(2):347-356.
36. Jetten M.J.A., Claessen S.M., Dejong C.H.C., Lahoz A., Castell J.V., van Delft J.H.M., et al. Interindividual variation in response to xenobiotic exposure established in precision-cut human liver slices. Toxicology 2014, 323(0):61-69.
37. Kara B., Daglioglu K., Doran F., Akkiz H., Sandikci M., Kara I.O. Expression of mesenchymal, hematopoietic, and biliary cell markers in adult rat hepatocytes after partial hepatectomy. Transplant. Proc. 2009, 41(10):4401-4404.
38. Kinkel A., Fernyhough M., Helterline D., Vierck J., Oberg K., Vance T., et al. Oil red-O stains non-adipogenic cells: a precautionary note. Cytotechnology 2004, 46(1):49-56.
39. Kostadinova R., Boess F., Applegate D., Suter L., Weiser T., Singer T., et al. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. Toxicol. Appl. Pharmacol. 2013, 268(1):1-16.
40. Lange J.R., Fabry B. Cell and tissue mechanics in cell migration. Exp. Cell Res. 2013, 319(16):2418-2423.
41. Lerche-Langrand C., Toutain H.J. Precision-cut liver slices: characteristics and use for in vitro pharmaco-toxicology. Toxicology 2000, 153(1-3):221-253.
42. Lewis W.H. Mesenchyme and mesothelium. J. Exp. Med. 1923, 38(3):257-262.
43. Li Y. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(6):2324-2329.
44. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193(1):265-275.
45. Mallat A. Autophagy: a multifaceted partner in liver fibrosis. Biomed. Res. Int. 2014, 2014.
46. Martignoni M. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin. Drug Metab. Toxicol. 2006, 2(6):875-894.
47. Martin H. Morphological and biochemical integrity of human liver slices in long-term culture: effects of oxygen tension. Cell Biol. Toxicol. 2002, 18(2):73-85.
48. Michelotti G.A., Xie G., Swiderska M., Choi S.S., Karaca G., Krüger L., et al. Smoothened is a master regulator of adult liver repair. J. Clin. Invest. 2013, 123(6):2380-2394.
49. Mutsaers S.E. Mesothelial cells: their structure, function and role in serosal repair. Respirology 2002, 7(3):171-191.
50. Nassir F. Role of mitochondria in nonalcoholic fatty liver disease. Int. J. Mol. Sci. 2014, 15(5):8713-8742.
51. Natarajan A., Wagner B., Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(43):17081-17086.
52. Nishioka Y. Regeneration of peritoneal mesothelium in a rat model of peritoneal fibrosis. Ren. Fail. 2008, 30(1):97-105.
53. Oliveira C.P. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz. J. Med. Biol. Res. 2006, 39(2):189-194.
54. Parrish A.R., Gandolfi A.J., Brendel K. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci. 1995, 57(21):1887-1901.
55. Price R.J., Ball S.E., Renwick A.B., Barton P.T., Beamand J.A., Lake B.G. Use of precision-cut rat liver slices for studies of xenobiotic metabolism and toxicity: comparison of the krumdieck and brendel tissue slicers. Xenobiotica 1998, 28(4):361-371.
56. Roberts R.A., Ganey P.E., Ju C., Kamendulis L.M., Rusyn I., Klaunig J.E. Role of the kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol. Sci. 2007, 96(1):2-15.
57. Rose M.L. Transplant-Associated Coronary Artery Vasculopathy 2001, Landes Bioscience.
58. Schaart G., Hesselink R., Keizer H., van Kranenburg G., Drost M., Hesselink M.C. A modified PAS stain combined with immunofluorescence for quantitative analyses of glycogen in muscle sections. Histochem. Cell Biol. 2004, 122(2):161-169.
59. Soldatow V.Y., LeCluyse E.L., Griffith L.G., Rusyn I. In vitro models for liver toxicity testing. Toxicol. Res. 2013, 2(1):23-39.
60. Song Y. Autophagy in hepatic fibrosis. Biomed. Res. Int. 2014, 2014.
61. Sugimoto R. High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen-activated protein kinase. Liver Int. 2005, 25(5):1018-1026.
62. Suzuki T. Hypoxia and fatty liver. World J. Gastroenterol. 2014, 20(41):15087-15097.
63. Toutain H.J., Moronvalle-Halley V., Sarsat J.P., Chelin C., Hoet D., Leroy D. Morphological and functional integrity of precision-cut rat liver slices in rotating organ culture and multiwell plate culture: effects of oxygen tension. Cell Biol. Toxicol. 1998, 14(3):175-190.
64. Valle M.T. Antigen-presenting function of human peritoneum mesothelial cells. Clin. Exp. Immunol. 1995, 101(1):172-176.
65. van de Bovenkamp M., Groothuis G.M.M., Meijer D.K.F., Olinga P. Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver. Toxicol. in Vitro 2008, 22(3):771-778.
66. Vasilyev A., Liu Y., Mudumana S., Mangos S., Lam P.Y., Majumdar A., Zhao J., Poon K.L., Kondrychyn I., Korzh V., Drummond I.A. Collective cell migration drives morphogenesis of the kidney nephron. PLoS Biol. 2009, 7(1).
67. Vickers A.E. Consequences of mitochondrial injury induced by pharmaceutical fatty acid oxidation inhibitors is characterized in human and rat liver slices. Toxicol. in Vitro 2006, 20(7):1173-1182.
68. Vickers A.E.M., Fisher R.L. Evaluation of drug-induced injury and human response in precision-cut tissue slices. Xenobiotica 2013, 43(1):29-40.
69. Vickers A.E.M., Saulnier M., Cruz E., Merema M.T., Rose K., Bentley P., et al. Organ slice viability extended for pathway characterization: an in vitro model to investigate fibrosis. Toxicol. Sci. 2004, 82(2):534-544.
70. Wei Y. Nonalcoholic fatty liver disease and mitochondrial dysfunction. World J. Gastroenterol. 2008, 14(2):193-199.
71. Westra I.M., Oosterhuis D., Groothuis G.M.M., Olinga P. Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol. Appl. Pharmacol. 2014, 274(2):328-338.
72. Xie G. Evidence for and against epithelial-to-mesenchymal transition in the liver. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305(12):881-890.
73. Yamamoto H., Murawaki Y., Kawasaki H. Hepatic collagen synthesis and degradation during liver regeneration after partial hepatectomy. Hepatology 1995, 21(1):155-161.
74. Yang L. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008, 26(8):2104-2113.
75. Yoshioka K. Cell proliferation activity of proliferating bile duct after bile duct ligation in rats. Vet. Pathol. 2005, 42(3):382-385.
76. Zhan L. Hypoxia-inducible factor-1alpha in hepatic fibrosis: a promising therapeutic target. Biochimie 2015, 108C:1-7.
77. Zhou W., Zhang Q., Qiao L. Pathogenesis of liver cirrhosis. World J. Gastroenterol. 2014, 20(23):7312-7324.